GTBIF — Green Thumb Industries Inc.

Is GTBIF overbought or oversold? Here is the current MarketMoodz read.

Healthcare · Drug Manufacturers - Specialty & Generic

Oversold As of November 17, 2026

Green Thumb Industries Inc. (GTBIF) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Healthcare name (Drug Manufacturers - Specialty & Generic) last closed at $6.01. The rating moved from Strong Oversold to Oversold on November 14, 2026.

See all oversold Healthcare stocks →

AI analysis

Green Thumb Industries (GTBIF) benefits from a diversified multi‑state retail and branded product platform and is showing signs of margin recovery driven by cost-control measures and mix improvement. Growth avenues include retail expansion in existing states, state legalization tailwinds, and selective M&A to consolidate share. However, the name remains exposed to sector-specific risks: regulatory uncertainty, aggressive state-level taxation, price pressure from oversupply, and periodic capital-market access challenges. Near-term performance will be driven by quarterly earnings execution, retail comps and wholesale pricing dynamics; longer-term upside depends on sustained margin expansion and prudent balance-sheet management.

Key factors

  • Multi-state retail footprint with established store network and recognizable consumer brands supports revenue diversification
  • Operational improvements and cost discipline have driven sequential margin recovery in recent quarters
  • Favorable long-term secular tailwinds from gradual state-level legalization and retail expansion opportunities
  • Potential M&A optionality to consolidate market share in key states and rationalize retail footprint
  • Pricing flexibility via branded product mix and wholesale/retail channel integration

Risks

  • Regulatory and political uncertainty at federal and state levels (taxation, banking access, interstate commerce restrictions)
  • High industry volatility: oversupply in some states can pressure wholesale prices and margins
  • Access to capital constraints and potential dilution from equity or convertible financings
  • Persistently high effective tax and compliance costs that depress net margins relative to other consumer sectors
  • Illicit market competition and local licensing complexities that can limit near‑term market share gains
  • Execution risk on store openings, integration of acquisitions and inventory management

See today's live rating, score and targets

Members see the live hourly rating for GTBIF — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.